Cargando…
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab
PURPOSE: People with hematologic malignancies have a significantly higher risk of developing severe and protracted forms of SARS-CoV-2 infection compared to immunocompetent patients, regardless of vaccination status. RESULTS: We describe two cases of prolonged SARS-CoV-2 infection with multiple rela...
Autores principales: | Franceschini, Erica, Pellegrino, Mariachiara, Todisco, Vera, Dolci, Giovanni, Bettelli, Francesca, Meschiari, Marianna, Bedini, Andrea., Fregni-Serpini, Giulia, Grottola, Antonella, Guaraldi, Giovanni, Pecorari, Monica, Sarti, Mario, Luppi, Mario, Perno, Carlo Federico, Mussini, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115373/ https://www.ncbi.nlm.nih.gov/pubmed/37076752 http://dx.doi.org/10.1007/s15010-023-02039-2 |
Ejemplares similares
-
A Retrospective Whole-Genome Sequencing Analysis of Carbapenem and Colistin-Resistant Klebsiella pneumoniae Nosocomial Strains Isolated during an MDR Surveillance Program
por: Gentile, Bernardina, et al.
Publicado: (2020) -
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440)
por: Stilgenbauer, Stephan, et al.
Publicado: (2020) -
MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial
por: Pott, Christiane, et al.
Publicado: (2019) -
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review
por: Dolci, Giovanni, et al.
Publicado: (2023) -
Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma
por: Grigg, Andrew, et al.
Publicado: (2017)